Can advances in personalized medicine change the landscape of treating rare genetic diseases?

The field of personalized medicine has been rapidly evolving, focusing on tailoring medical treatment to the individual characteristics of each patient. In particular, genetic profiling and advances in biotechnology are offering new hopes for patients with rare genetic diseases, where traditional one-size-fits-all approaches have often failed. This question probes the potential impact of these scientific advancements on the treatment and quality of life for individuals affected by rare genetic conditions, considering both the challenges and opportunities these innovations present. By leveraging genomic data and understanding molecular mechanisms, can personalized therapies effectively revolutionize the management and outcomes for these often-overlooked diseases?